Xenetic Biosciences, Inc. — Investor Relations & Filings
Filings indexed
466
across all filing types
Latest filing
2026-05-13
Regulatory Filings
Country
US
United States of America
Listing
US
XBIO
Xenetic Biosciences, Inc. is a biopharmaceutical company focused on advancing proprietary technology platforms for immune-oncology. The company's development pipeline is centered on its XCART platform, a personalized CAR T-cell therapy technology, and its DNase-based oncology platform. The DNase platform is designed to improve cancer therapies by targeting Neutrophil Extracellular Traps (NETs), which are implicated in cancer progression, metastasis, and resistance to treatments. Xenetic's research aims to address multiple high-value, difficult-to-treat cancer indications, including pancreatic cancer and other solid tumors.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 8-K - Xenetic Biosciences, Inc. (0001534525) (Filer) | 2026-05-13 | English | |
| 10-K/A - Xenetic Biosciences, Inc. (0001534525) (Filer) | 2026-04-24 | English | |
| SCHEDULE 13G Filing | 2026-02-12 | English | |
| FORM 8-K | 2026-01-09 | English | |
| Director's Dealing 2026 | 2026-01-05 | English | |
| Director's Dealing 2026 | 2026-01-05 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
8 filings
| |||||
| 45579672 | 8-K - Xenetic Biosciences, Inc. (0001534525) (Filer) | 2026-05-13 | English | ||
| 36286132 | 10-K/A - Xenetic Biosciences, Inc. (0001534525) (Filer) | 2026-04-24 | English | ||
| 30437881 | SCHEDULE 13G Filing | 2026-02-12 | English | ||
| 12513673 | FORM 8-K | 2026-01-09 | English | ||
| 12513674 | Director's Dealing 2026 | 2026-01-05 | English | ||
| 12513675 | Director's Dealing 2026 | 2026-01-05 | English | ||
| 12513676 | Director's Dealing 2026 | 2026-01-05 | English | ||
| 12513677 | Director's Dealing 2026 | 2026-01-05 | English | ||
|
2025
7 filings
| |||||
| 12513678 | ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS | 2025-12-11 | English | ||
| 12513681 | CURRENT REPORT | 2025-12-11 | English | ||
| 12513679 | CURRENT REPORT | 2025-11-13 | English | ||
| 12513689 | FORM 10-Q FOR SEP 2025 | 2025-11-12 | English | ||
| 12513684 | ANNUAL REPORT TO SECURITY HOLDERS | 2025-10-31 | English | ||
| 12513686 | DEFINITIVE ADDITIONAL MATERIALS | 2025-10-31 | English | ||
| 12513691 | DEFINITIVE PROXY STATEMENT | 2025-10-31 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
Xenetic Biosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/35426/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=35426 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=35426 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=35426 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 35426}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Xenetic Biosciences, Inc. (id: 35426)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.